Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

ErbB3 ablation impairs PI3K/Akt-dependent mammary tumorigenesis.

Cook RS, Garrett JT, Sánchez V, Stanford JC, Young C, Chakrabarty A, Rinehart C, Zhang Y, Wu Y, Greenberger L, Horak ID, Arteaga CL.

Cancer Res. 2011 Jun 1;71(11):3941-51. doi: 10.1158/0008-5472.CAN-10-3775. Epub 2011 Apr 11.

2.

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer.

Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI, He X, Perou CM.

Breast Cancer Res. 2010;12(5):R68. doi: 10.1186/bcr2635. Epub 2010 Sep 2.

3.

Insights into the cell of origin in breast cancer and breast cancer stem cells.

Lindeman GJ, Visvader JE.

Asia Pac J Clin Oncol. 2010 Jun;6(2):89-97. doi: 10.1111/j.1743-7563.2010.01279.x. Review.

PMID:
20565420
4.

Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways.

Lim E, Wu D, Pal B, Bouras T, Asselin-Labat ML, Vaillant F, Yagita H, Lindeman GJ, Smyth GK, Visvader JE.

Breast Cancer Res. 2010;12(2):R21. doi: 10.1186/bcr2560. Epub 2010 Mar 26.

5.

Targeting the PI3K signaling pathway in cancer.

Wong KK, Engelman JA, Cantley LC.

Curr Opin Genet Dev. 2010 Feb;20(1):87-90. doi: 10.1016/j.gde.2009.11.002. Epub 2009 Dec 16. Review.

6.

Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers.

Lim E, Vaillant F, Wu D, Forrest NC, Pal B, Hart AH, Asselin-Labat ML, Gyorki DE, Ward T, Partanen A, Feleppa F, Huschtscha LI, Thorne HJ; kConFab, Fox SB, Yan M, French JD, Brown MA, Smyth GK, Visvader JE, Lindeman GJ.

Nat Med. 2009 Aug;15(8):907-13. doi: 10.1038/nm.2000. Epub 2009 Aug 2.

PMID:
19648928
7.

Delineating the epithelial hierarchy in the mouse mammary gland.

Asselin-Labat ML, Vaillant F, Shackleton M, Bouras T, Lindeman GJ, Visvader JE.

Cold Spring Harb Symp Quant Biol. 2008;73:469-78. doi: 10.1101/sqb.2008.73.020. Epub 2008 Nov 6. Review.

PMID:
19022771
8.

ErbB3 is required for ductal morphogenesis in the mouse mammary gland.

Jackson-Fisher AJ, Bellinger G, Breindel JL, Tavassoli FA, Booth CJ, Duong JK, Stern DF.

Breast Cancer Res. 2008;10(6):R96. doi: 10.1186/bcr2198. Epub 2008 Nov 18.

9.

Collective epithelial migration and cell rearrangements drive mammary branching morphogenesis.

Ewald AJ, Brenot A, Duong M, Chan BS, Werb Z.

Dev Cell. 2008 Apr;14(4):570-81. doi: 10.1016/j.devcel.2008.03.003.

10.

The Ets transcription factor Elf5 specifies mammary alveolar cell fate.

Oakes SR, Naylor MJ, Asselin-Labat ML, Blazek KD, Gardiner-Garden M, Hilton HN, Kazlauskas M, Pritchard MA, Chodosh LA, Pfeffer PL, Lindeman GJ, Visvader JE, Ormandy CJ.

Genes Dev. 2008 Mar 1;22(5):581-6. doi: 10.1101/gad.1614608.

11.

Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors.

Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, Hu Z, Rasmussen KE, Jones LP, Assefnia S, Chandrasekharan S, Backlund MG, Yin Y, Khramtsov AI, Bastein R, Quackenbush J, Glazer RI, Brown PH, Green JE, Kopelovich L, Furth PA, Palazzo JP, Olopade OI, Bernard PS, Churchill GA, Van Dyke T, Perou CM.

Genome Biol. 2007;8(5):R76.

12.

ERalpha-CITED1 co-regulated genes expressed during pubertal mammary gland development: implications for breast cancer prognosis.

McBryan J, Howlin J, Kenny PA, Shioda T, Martin F.

Oncogene. 2007 Sep 27;26(44):6406-19. Epub 2007 May 7.

PMID:
17486082
13.

The MAPK(ERK-1,2) pathway integrates distinct and antagonistic signals from TGFalpha and FGF7 in morphogenesis of mouse mammary epithelium.

Fata JE, Mori H, Ewald AJ, Zhang H, Yao E, Werb Z, Bissell MJ.

Dev Biol. 2007 Jun 1;306(1):193-207. Epub 2007 Mar 16.

14.

Gene targeting of ErbB3 using a Cre-mediated unidirectional DNA inversion strategy.

Qu S, Rinehart C, Wu HH, Wang SE, Carter B, Xin H, Kotlikoff M, Arteaga CL.

Genesis. 2006 Oct;44(10):477-86.

PMID:
16991114
15.

EGF-ERBB signalling: towards the systems level.

Citri A, Yarden Y.

Nat Rev Mol Cell Biol. 2006 Jul;7(7):505-16. Review.

PMID:
16829981
16.

Common markers of proliferation.

Whitfield ML, George LK, Grant GD, Perou CM.

Nat Rev Cancer. 2006 Feb;6(2):99-106. Review.

PMID:
16491069
17.

Socs2 and elf5 mediate prolactin-induced mammary gland development.

Harris J, Stanford PM, Sutherland K, Oakes SR, Naylor MJ, Robertson FG, Blazek KD, Kazlauskas M, Hilton HN, Wittlin S, Alexander WS, Lindeman GJ, Visvader JE, Ormandy CJ.

Mol Endocrinol. 2006 May;20(5):1177-87. Epub 2006 Feb 9.

PMID:
16469767
18.

The epidermal growth factor receptor family.

Bazley LA, Gullick WJ.

Endocr Relat Cancer. 2005 Jul;12 Suppl 1:S17-27. Review.

19.

Elf5 is essential for early embryogenesis and mammary gland development during pregnancy and lactation.

Zhou J, Chehab R, Tkalcevic J, Naylor MJ, Harris J, Wilson TJ, Tsao S, Tellis I, Zavarsek S, Xu D, Lapinskas EJ, Visvader J, Lindeman GJ, Thomas R, Ormandy CJ, Hertzog PJ, Kola I, Pritchard MA.

EMBO J. 2005 Feb 9;24(3):635-44. Epub 2005 Jan 13.

20.

Targeted disruption of ErbB2/Neu in the mammary epithelium results in impaired ductal outgrowth.

Andrechek ER, White D, Muller WJ.

Oncogene. 2005 Jan 27;24(5):932-7.

PMID:
15580295

Supplemental Content

Support Center